一项多中心、随机、双盲、安慰剂对照的交叉试验，旨在评估唑米曲坦鼻喷雾剂治疗6 - 11岁急性偏头痛患者的疗效和安全性，并进行开放标签扩展

Headache: The Journal of Head and Face Pain Pub Date : 2022-10-01 DOI:10.1111/head.14391

M. Yonker, J. McVige, L. Zeitlin, H. Visser

{"title":"一项多中心、随机、双盲、安慰剂对照的交叉试验，旨在评估唑米曲坦鼻喷雾剂治疗6 - 11岁急性偏头痛患者的疗效和安全性，并进行开放标签扩展","authors":"M. Yonker, J. McVige, L. Zeitlin, H. Visser","doi":"10.1111/head.14391","DOIUrl":null,"url":null,"abstract":"To evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in patients aged 6 to 11 years.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"108 1","pages":"1207 - 1217"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open‐label extension\",\"authors\":\"M. Yonker, J. McVige, L. Zeitlin, H. Visser\",\"doi\":\"10.1111/head.14391\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in patients aged 6 to 11 years.\",\"PeriodicalId\":12845,\"journal\":{\"name\":\"Headache: The Journal of Head and Face Pain\",\"volume\":\"108 1\",\"pages\":\"1207 - 1217\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Headache: The Journal of Head and Face Pain\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/head.14391\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Headache: The Journal of Head and Face Pain","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/head.14391","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

摘要

评价唑米曲坦鼻喷雾剂(ZNS)治疗6 ~ 11岁急性偏头痛患者的疗效和安全性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open‐label extension

To evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in patients aged 6 to 11 years.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Headache: The Journal of Head and Face Pain

自引率

0.00%

发文量